Journey Medical Corp Stock Current Valuation
| DERM Stock | USD 6.24 0.27 4.52% |
Valuation analysis of Journey Medical Corp helps investors to measure Journey Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 2nd of April 2025, Enterprise Value Over EBITDA is likely to grow to -6.76. In addition to that, Enterprise Value Multiple is likely to grow to -6.76. Fundamental drivers impacting Journey Medical's valuation include:
Undervalued
Today
Please note that Journey Medical's price fluctuation is slightly risky at this time. Calculation of the real value of Journey Medical Corp is based on 3 months time horizon. Increasing Journey Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Journey stock is determined by what a typical buyer is willing to pay for full or partial control of Journey Medical Corp. Since Journey Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Journey Stock. However, Journey Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.24 | Real 6.87 | Target 10.0 | Hype 6.02 | Naive 6.08 |
The intrinsic value of Journey Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Journey Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Journey Medical Corp helps investors to forecast how Journey stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Journey Medical more accurately as focusing exclusively on Journey Medical's fundamentals will not take into account other important factors: Journey Medical Corp Company Current Valuation Analysis
Journey Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Journey Medical Current Valuation | 142.71 M |
Most of Journey Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Journey Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Journey Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Journey Medical is extremely important. It helps to project a fair market value of Journey Stock properly, considering its historical fundamentals such as Current Valuation. Since Journey Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Journey Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Journey Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Journey Current Valuation Historical Pattern
Today, most investors in Journey Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Journey Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Journey Medical current valuation as a starting point in their analysis.
Journey Medical Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Journey Medical Corp has a Current Valuation of 142.71 M. This is 99.01% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.14% higher than that of the company.
Journey Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Journey Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Journey Medical could also be used in its relative valuation, which is a method of valuing Journey Medical by comparing valuation metrics of similar companies.Journey Medical is currently under evaluation in current valuation category among its peers.
Journey Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Journey Medical from analyzing Journey Medical's financial statements. These drivers represent accounts that assess Journey Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Journey Medical's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 155.4M | 45.0M | 24.6M | 95.3M | 109.6M | 105.4M |
Journey Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Journey Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Journey Medical's managers, analysts, and investors.Environmental | Governance | Social |
Journey Fundamentals
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 142.71 M | ||||
| Shares Outstanding | 17.1 M | ||||
| Shares Owned By Insiders | 26.12 % | ||||
| Shares Owned By Institutions | 22.18 % | ||||
| Number Of Shares Shorted | 117.33 K | ||||
| Price To Earning | (9.50) X | ||||
| Price To Book | 6.87 X | ||||
| Price To Sales | 2.46 X | ||||
| Revenue | 56.13 M | ||||
| Gross Profit | 35.26 M | ||||
| EBITDA | (8.4 M) | ||||
| Net Income | (14.67 M) | ||||
| Cash And Equivalents | 38.14 M | ||||
| Cash Per Share | 2.17 X | ||||
| Total Debt | 201 K | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 1.40 X | ||||
| Book Value Per Share | 0.91 X | ||||
| Cash Flow From Operations | (9.13 M) | ||||
| Short Ratio | 2.30 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 9.88 | ||||
| Beta | 0.98 | ||||
| Market Capitalization | 137.93 M | ||||
| Total Asset | 80.24 M | ||||
| Retained Earnings | (87.03 M) | ||||
| Working Capital | 13 M | ||||
| Current Asset | 217.23 M | ||||
| Current Liabilities | 25.9 M | ||||
| Net Asset | 80.24 M |
About Journey Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Journey Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Journey Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Journey Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Journey Medical Piotroski F Score and Journey Medical Altman Z Score analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.